Global Artificial Intelligence (AI) in Pharmaceutical Market Research Report 2024(Status and Outlook)
Report Overview
This report provides a deep insight into the global Artificial Intelligence (AI) in Pharmaceutical market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Artificial Intelligence (AI) in Pharmaceutical Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Artificial Intelligence (AI) in Pharmaceutical market in any manner.
Global Artificial Intelligence (AI) in Pharmaceutical Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
AstraZeneca LLC
Atomwise Inc
Bayer AG
Cloud Pharmaceuticals Inc
GNS Healthcare
IBM Watson
Merck & Co.
Microsoft Corporation
Novartis AG
NVIDIA Corporation
Pfizer Inc.
Recursion Pharmaceuticals Inc.
XtalPi Inc
Market Segmentation (by Type)
Hardware
Software
Market Segmentation (by Application)
Pharmaceutical Company
Institute of Biology
Others
Geographic Segmentation
%li%North America (USA, Canada, Mexico)
%li%Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
%li%Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
%li%South America (Brazil, Argentina, Columbia, Rest of South America)
%li%The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
%li%Industry drivers, restraints, and opportunities covered in the study
%li%Neutral perspective on the market performance
%li%Recent industry trends and developments
%li%Competitive landscape & strategies of key players
%li%Potential & niche segments and regions exhibiting promising growth covered
%li%Historical, current, and projected market size, in terms of value
%li%In-depth analysis of the Artificial Intelligence (AI) in Pharmaceutical Market
%li%Overview of the regional outlook of the Artificial Intelligence (AI) in Pharmaceutical Market:
Key Reasons to Buy this Report:
%li%Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
%li%This enables you to anticipate market changes to remain ahead of your competitors
%li%You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
%li%The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
%li%Provision of market value (USD Billion) data for each segment and sub-segment
%li%Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
%li%Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
%li%Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
%li%Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
%li%The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
%li%Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
%li%Provides insight into the market through Value Chain
%li%Market dynamics scenario, along with growth opportunities of the market in the years to come
%li%6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Artificial Intelligence (AI) in Pharmaceutical Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
This report provides a deep insight into the global Artificial Intelligence (AI) in Pharmaceutical market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Artificial Intelligence (AI) in Pharmaceutical Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Artificial Intelligence (AI) in Pharmaceutical market in any manner.
Global Artificial Intelligence (AI) in Pharmaceutical Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
AstraZeneca LLC
Atomwise Inc
Bayer AG
Cloud Pharmaceuticals Inc
GNS Healthcare
IBM Watson
Merck & Co.
Microsoft Corporation
Novartis AG
NVIDIA Corporation
Pfizer Inc.
Recursion Pharmaceuticals Inc.
XtalPi Inc
Market Segmentation (by Type)
Hardware
Software
Market Segmentation (by Application)
Pharmaceutical Company
Institute of Biology
Others
Geographic Segmentation
%li%North America (USA, Canada, Mexico)
%li%Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
%li%Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
%li%South America (Brazil, Argentina, Columbia, Rest of South America)
%li%The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
%li%Industry drivers, restraints, and opportunities covered in the study
%li%Neutral perspective on the market performance
%li%Recent industry trends and developments
%li%Competitive landscape & strategies of key players
%li%Potential & niche segments and regions exhibiting promising growth covered
%li%Historical, current, and projected market size, in terms of value
%li%In-depth analysis of the Artificial Intelligence (AI) in Pharmaceutical Market
%li%Overview of the regional outlook of the Artificial Intelligence (AI) in Pharmaceutical Market:
Key Reasons to Buy this Report:
%li%Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
%li%This enables you to anticipate market changes to remain ahead of your competitors
%li%You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
%li%The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
%li%Provision of market value (USD Billion) data for each segment and sub-segment
%li%Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
%li%Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
%li%Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
%li%Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
%li%The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
%li%Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
%li%Provides insight into the market through Value Chain
%li%Market dynamics scenario, along with growth opportunities of the market in the years to come
%li%6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Artificial Intelligence (AI) in Pharmaceutical Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Artificial Intelligence (AI) in Pharmaceutical
1.2 Key Market Segments
1.2.1 Artificial Intelligence (AI) in Pharmaceutical Segment by Type
1.2.2 Artificial Intelligence (AI) in Pharmaceutical Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ARTIFICIAL INTELLIGENCE (AI) IN PHARMACEUTICAL MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Artificial Intelligence (AI) in Pharmaceutical Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Artificial Intelligence (AI) in Pharmaceutical Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ARTIFICIAL INTELLIGENCE (AI) IN PHARMACEUTICAL MARKET COMPETITIVE LANDSCAPE
3.1 Global Artificial Intelligence (AI) in Pharmaceutical Sales by Manufacturers (2019-2024)
3.2 Global Artificial Intelligence (AI) in Pharmaceutical Revenue Market Share by Manufacturers (2019-2024)
3.3 Artificial Intelligence (AI) in Pharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Artificial Intelligence (AI) in Pharmaceutical Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Artificial Intelligence (AI) in Pharmaceutical Sales Sites, Area Served, Product Type
3.6 Artificial Intelligence (AI) in Pharmaceutical Market Competitive Situation and Trends
3.6.1 Artificial Intelligence (AI) in Pharmaceutical Market Concentration Rate
3.6.2 Global 5 and 10 Largest Artificial Intelligence (AI) in Pharmaceutical Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ARTIFICIAL INTELLIGENCE (AI) IN PHARMACEUTICAL INDUSTRY CHAIN ANALYSIS
4.1 Artificial Intelligence (AI) in Pharmaceutical Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ARTIFICIAL INTELLIGENCE (AI) IN PHARMACEUTICAL MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ARTIFICIAL INTELLIGENCE (AI) IN PHARMACEUTICAL MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Artificial Intelligence (AI) in Pharmaceutical Sales Market Share by Type (2019-2024)
6.3 Global Artificial Intelligence (AI) in Pharmaceutical Market Size Market Share by Type (2019-2024)
6.4 Global Artificial Intelligence (AI) in Pharmaceutical Price by Type (2019-2024)
7 ARTIFICIAL INTELLIGENCE (AI) IN PHARMACEUTICAL MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Artificial Intelligence (AI) in Pharmaceutical Market Sales by Application (2019-2024)
7.3 Global Artificial Intelligence (AI) in Pharmaceutical Market Size (M USD) by Application (2019-2024)
7.4 Global Artificial Intelligence (AI) in Pharmaceutical Sales Growth Rate by Application (2019-2024)
8 ARTIFICIAL INTELLIGENCE (AI) IN PHARMACEUTICAL MARKET SEGMENTATION BY REGION
8.1 Global Artificial Intelligence (AI) in Pharmaceutical Sales by Region
8.1.1 Global Artificial Intelligence (AI) in Pharmaceutical Sales by Region
8.1.2 Global Artificial Intelligence (AI) in Pharmaceutical Sales Market Share by Region
8.2 North America
8.2.1 North America Artificial Intelligence (AI) in Pharmaceutical Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Artificial Intelligence (AI) in Pharmaceutical Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Artificial Intelligence (AI) in Pharmaceutical Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Artificial Intelligence (AI) in Pharmaceutical Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Artificial Intelligence (AI) in Pharmaceutical Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 AstraZeneca LLC
9.1.1 AstraZeneca LLC Artificial Intelligence (AI) in Pharmaceutical Basic Information
9.1.2 AstraZeneca LLC Artificial Intelligence (AI) in Pharmaceutical Product Overview
9.1.3 AstraZeneca LLC Artificial Intelligence (AI) in Pharmaceutical Product Market Performance
9.1.4 AstraZeneca LLC Business Overview
9.1.5 AstraZeneca LLC Artificial Intelligence (AI) in Pharmaceutical SWOT Analysis
9.1.6 AstraZeneca LLC Recent Developments
9.2 Atomwise Inc
9.2.1 Atomwise Inc Artificial Intelligence (AI) in Pharmaceutical Basic Information
9.2.2 Atomwise Inc Artificial Intelligence (AI) in Pharmaceutical Product Overview
9.2.3 Atomwise Inc Artificial Intelligence (AI) in Pharmaceutical Product Market Performance
9.2.4 Atomwise Inc Business Overview
9.2.5 Atomwise Inc Artificial Intelligence (AI) in Pharmaceutical SWOT Analysis
9.2.6 Atomwise Inc Recent Developments
9.3 Bayer AG
9.3.1 Bayer AG Artificial Intelligence (AI) in Pharmaceutical Basic Information
9.3.2 Bayer AG Artificial Intelligence (AI) in Pharmaceutical Product Overview
9.3.3 Bayer AG Artificial Intelligence (AI) in Pharmaceutical Product Market Performance
9.3.4 Bayer AG Artificial Intelligence (AI) in Pharmaceutical SWOT Analysis
9.3.5 Bayer AG Business Overview
9.3.6 Bayer AG Recent Developments
9.4 Cloud Pharmaceuticals Inc
9.4.1 Cloud Pharmaceuticals Inc Artificial Intelligence (AI) in Pharmaceutical Basic Information
9.4.2 Cloud Pharmaceuticals Inc Artificial Intelligence (AI) in Pharmaceutical Product Overview
9.4.3 Cloud Pharmaceuticals Inc Artificial Intelligence (AI) in Pharmaceutical Product Market Performance
9.4.4 Cloud Pharmaceuticals Inc Business Overview
9.4.5 Cloud Pharmaceuticals Inc Recent Developments
9.5 GNS Healthcare
9.5.1 GNS Healthcare Artificial Intelligence (AI) in Pharmaceutical Basic Information
9.5.2 GNS Healthcare Artificial Intelligence (AI) in Pharmaceutical Product Overview
9.5.3 GNS Healthcare Artificial Intelligence (AI) in Pharmaceutical Product Market Performance
9.5.4 GNS Healthcare Business Overview
9.5.5 GNS Healthcare Recent Developments
9.6 IBM Watson
9.6.1 IBM Watson Artificial Intelligence (AI) in Pharmaceutical Basic Information
9.6.2 IBM Watson Artificial Intelligence (AI) in Pharmaceutical Product Overview
9.6.3 IBM Watson Artificial Intelligence (AI) in Pharmaceutical Product Market Performance
9.6.4 IBM Watson Business Overview
9.6.5 IBM Watson Recent Developments
9.7 Merck and Co.
9.7.1 Merck and Co. Artificial Intelligence (AI) in Pharmaceutical Basic Information
9.7.2 Merck and Co. Artificial Intelligence (AI) in Pharmaceutical Product Overview
9.7.3 Merck and Co. Artificial Intelligence (AI) in Pharmaceutical Product Market Performance
9.7.4 Merck and Co. Business Overview
9.7.5 Merck and Co. Recent Developments
9.8 Microsoft Corporation
9.8.1 Microsoft Corporation Artificial Intelligence (AI) in Pharmaceutical Basic Information
9.8.2 Microsoft Corporation Artificial Intelligence (AI) in Pharmaceutical Product Overview
9.8.3 Microsoft Corporation Artificial Intelligence (AI) in Pharmaceutical Product Market Performance
9.8.4 Microsoft Corporation Business Overview
9.8.5 Microsoft Corporation Recent Developments
9.9 Novartis AG
9.9.1 Novartis AG Artificial Intelligence (AI) in Pharmaceutical Basic Information
9.9.2 Novartis AG Artificial Intelligence (AI) in Pharmaceutical Product Overview
9.9.3 Novartis AG Artificial Intelligence (AI) in Pharmaceutical Product Market Performance
9.9.4 Novartis AG Business Overview
9.9.5 Novartis AG Recent Developments
9.10 NVIDIA Corporation
9.10.1 NVIDIA Corporation Artificial Intelligence (AI) in Pharmaceutical Basic Information
9.10.2 NVIDIA Corporation Artificial Intelligence (AI) in Pharmaceutical Product Overview
9.10.3 NVIDIA Corporation Artificial Intelligence (AI) in Pharmaceutical Product Market Performance
9.10.4 NVIDIA Corporation Business Overview
9.10.5 NVIDIA Corporation Recent Developments
9.11 Pfizer Inc.
9.11.1 Pfizer Inc. Artificial Intelligence (AI) in Pharmaceutical Basic Information
9.11.2 Pfizer Inc. Artificial Intelligence (AI) in Pharmaceutical Product Overview
9.11.3 Pfizer Inc. Artificial Intelligence (AI) in Pharmaceutical Product Market Performance
9.11.4 Pfizer Inc. Business Overview
9.11.5 Pfizer Inc. Recent Developments
9.12 Recursion Pharmaceuticals Inc.
9.12.1 Recursion Pharmaceuticals Inc. Artificial Intelligence (AI) in Pharmaceutical Basic Information
9.12.2 Recursion Pharmaceuticals Inc. Artificial Intelligence (AI) in Pharmaceutical Product Overview
9.12.3 Recursion Pharmaceuticals Inc. Artificial Intelligence (AI) in Pharmaceutical Product Market Performance
9.12.4 Recursion Pharmaceuticals Inc. Business Overview
9.12.5 Recursion Pharmaceuticals Inc. Recent Developments
9.13 XtalPi Inc
9.13.1 XtalPi Inc Artificial Intelligence (AI) in Pharmaceutical Basic Information
9.13.2 XtalPi Inc Artificial Intelligence (AI) in Pharmaceutical Product Overview
9.13.3 XtalPi Inc Artificial Intelligence (AI) in Pharmaceutical Product Market Performance
9.13.4 XtalPi Inc Business Overview
9.13.5 XtalPi Inc Recent Developments
10 ARTIFICIAL INTELLIGENCE (AI) IN PHARMACEUTICAL MARKET FORECAST BY REGION
10.1 Global Artificial Intelligence (AI) in Pharmaceutical Market Size Forecast
10.2 Global Artificial Intelligence (AI) in Pharmaceutical Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Artificial Intelligence (AI) in Pharmaceutical Market Size Forecast by Country
10.2.3 Asia Pacific Artificial Intelligence (AI) in Pharmaceutical Market Size Forecast by Region
10.2.4 South America Artificial Intelligence (AI) in Pharmaceutical Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Artificial Intelligence (AI) in Pharmaceutical by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Artificial Intelligence (AI) in Pharmaceutical Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Artificial Intelligence (AI) in Pharmaceutical by Type (2025-2030)
11.1.2 Global Artificial Intelligence (AI) in Pharmaceutical Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Artificial Intelligence (AI) in Pharmaceutical by Type (2025-2030)
11.2 Global Artificial Intelligence (AI) in Pharmaceutical Market Forecast by Application (2025-2030)
11.2.1 Global Artificial Intelligence (AI) in Pharmaceutical Sales (K Units) Forecast by Application
11.2.2 Global Artificial Intelligence (AI) in Pharmaceutical Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Artificial Intelligence (AI) in Pharmaceutical
1.2 Key Market Segments
1.2.1 Artificial Intelligence (AI) in Pharmaceutical Segment by Type
1.2.2 Artificial Intelligence (AI) in Pharmaceutical Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ARTIFICIAL INTELLIGENCE (AI) IN PHARMACEUTICAL MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Artificial Intelligence (AI) in Pharmaceutical Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Artificial Intelligence (AI) in Pharmaceutical Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ARTIFICIAL INTELLIGENCE (AI) IN PHARMACEUTICAL MARKET COMPETITIVE LANDSCAPE
3.1 Global Artificial Intelligence (AI) in Pharmaceutical Sales by Manufacturers (2019-2024)
3.2 Global Artificial Intelligence (AI) in Pharmaceutical Revenue Market Share by Manufacturers (2019-2024)
3.3 Artificial Intelligence (AI) in Pharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Artificial Intelligence (AI) in Pharmaceutical Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Artificial Intelligence (AI) in Pharmaceutical Sales Sites, Area Served, Product Type
3.6 Artificial Intelligence (AI) in Pharmaceutical Market Competitive Situation and Trends
3.6.1 Artificial Intelligence (AI) in Pharmaceutical Market Concentration Rate
3.6.2 Global 5 and 10 Largest Artificial Intelligence (AI) in Pharmaceutical Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ARTIFICIAL INTELLIGENCE (AI) IN PHARMACEUTICAL INDUSTRY CHAIN ANALYSIS
4.1 Artificial Intelligence (AI) in Pharmaceutical Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ARTIFICIAL INTELLIGENCE (AI) IN PHARMACEUTICAL MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ARTIFICIAL INTELLIGENCE (AI) IN PHARMACEUTICAL MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Artificial Intelligence (AI) in Pharmaceutical Sales Market Share by Type (2019-2024)
6.3 Global Artificial Intelligence (AI) in Pharmaceutical Market Size Market Share by Type (2019-2024)
6.4 Global Artificial Intelligence (AI) in Pharmaceutical Price by Type (2019-2024)
7 ARTIFICIAL INTELLIGENCE (AI) IN PHARMACEUTICAL MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Artificial Intelligence (AI) in Pharmaceutical Market Sales by Application (2019-2024)
7.3 Global Artificial Intelligence (AI) in Pharmaceutical Market Size (M USD) by Application (2019-2024)
7.4 Global Artificial Intelligence (AI) in Pharmaceutical Sales Growth Rate by Application (2019-2024)
8 ARTIFICIAL INTELLIGENCE (AI) IN PHARMACEUTICAL MARKET SEGMENTATION BY REGION
8.1 Global Artificial Intelligence (AI) in Pharmaceutical Sales by Region
8.1.1 Global Artificial Intelligence (AI) in Pharmaceutical Sales by Region
8.1.2 Global Artificial Intelligence (AI) in Pharmaceutical Sales Market Share by Region
8.2 North America
8.2.1 North America Artificial Intelligence (AI) in Pharmaceutical Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Artificial Intelligence (AI) in Pharmaceutical Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Artificial Intelligence (AI) in Pharmaceutical Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Artificial Intelligence (AI) in Pharmaceutical Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Artificial Intelligence (AI) in Pharmaceutical Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 AstraZeneca LLC
9.1.1 AstraZeneca LLC Artificial Intelligence (AI) in Pharmaceutical Basic Information
9.1.2 AstraZeneca LLC Artificial Intelligence (AI) in Pharmaceutical Product Overview
9.1.3 AstraZeneca LLC Artificial Intelligence (AI) in Pharmaceutical Product Market Performance
9.1.4 AstraZeneca LLC Business Overview
9.1.5 AstraZeneca LLC Artificial Intelligence (AI) in Pharmaceutical SWOT Analysis
9.1.6 AstraZeneca LLC Recent Developments
9.2 Atomwise Inc
9.2.1 Atomwise Inc Artificial Intelligence (AI) in Pharmaceutical Basic Information
9.2.2 Atomwise Inc Artificial Intelligence (AI) in Pharmaceutical Product Overview
9.2.3 Atomwise Inc Artificial Intelligence (AI) in Pharmaceutical Product Market Performance
9.2.4 Atomwise Inc Business Overview
9.2.5 Atomwise Inc Artificial Intelligence (AI) in Pharmaceutical SWOT Analysis
9.2.6 Atomwise Inc Recent Developments
9.3 Bayer AG
9.3.1 Bayer AG Artificial Intelligence (AI) in Pharmaceutical Basic Information
9.3.2 Bayer AG Artificial Intelligence (AI) in Pharmaceutical Product Overview
9.3.3 Bayer AG Artificial Intelligence (AI) in Pharmaceutical Product Market Performance
9.3.4 Bayer AG Artificial Intelligence (AI) in Pharmaceutical SWOT Analysis
9.3.5 Bayer AG Business Overview
9.3.6 Bayer AG Recent Developments
9.4 Cloud Pharmaceuticals Inc
9.4.1 Cloud Pharmaceuticals Inc Artificial Intelligence (AI) in Pharmaceutical Basic Information
9.4.2 Cloud Pharmaceuticals Inc Artificial Intelligence (AI) in Pharmaceutical Product Overview
9.4.3 Cloud Pharmaceuticals Inc Artificial Intelligence (AI) in Pharmaceutical Product Market Performance
9.4.4 Cloud Pharmaceuticals Inc Business Overview
9.4.5 Cloud Pharmaceuticals Inc Recent Developments
9.5 GNS Healthcare
9.5.1 GNS Healthcare Artificial Intelligence (AI) in Pharmaceutical Basic Information
9.5.2 GNS Healthcare Artificial Intelligence (AI) in Pharmaceutical Product Overview
9.5.3 GNS Healthcare Artificial Intelligence (AI) in Pharmaceutical Product Market Performance
9.5.4 GNS Healthcare Business Overview
9.5.5 GNS Healthcare Recent Developments
9.6 IBM Watson
9.6.1 IBM Watson Artificial Intelligence (AI) in Pharmaceutical Basic Information
9.6.2 IBM Watson Artificial Intelligence (AI) in Pharmaceutical Product Overview
9.6.3 IBM Watson Artificial Intelligence (AI) in Pharmaceutical Product Market Performance
9.6.4 IBM Watson Business Overview
9.6.5 IBM Watson Recent Developments
9.7 Merck and Co.
9.7.1 Merck and Co. Artificial Intelligence (AI) in Pharmaceutical Basic Information
9.7.2 Merck and Co. Artificial Intelligence (AI) in Pharmaceutical Product Overview
9.7.3 Merck and Co. Artificial Intelligence (AI) in Pharmaceutical Product Market Performance
9.7.4 Merck and Co. Business Overview
9.7.5 Merck and Co. Recent Developments
9.8 Microsoft Corporation
9.8.1 Microsoft Corporation Artificial Intelligence (AI) in Pharmaceutical Basic Information
9.8.2 Microsoft Corporation Artificial Intelligence (AI) in Pharmaceutical Product Overview
9.8.3 Microsoft Corporation Artificial Intelligence (AI) in Pharmaceutical Product Market Performance
9.8.4 Microsoft Corporation Business Overview
9.8.5 Microsoft Corporation Recent Developments
9.9 Novartis AG
9.9.1 Novartis AG Artificial Intelligence (AI) in Pharmaceutical Basic Information
9.9.2 Novartis AG Artificial Intelligence (AI) in Pharmaceutical Product Overview
9.9.3 Novartis AG Artificial Intelligence (AI) in Pharmaceutical Product Market Performance
9.9.4 Novartis AG Business Overview
9.9.5 Novartis AG Recent Developments
9.10 NVIDIA Corporation
9.10.1 NVIDIA Corporation Artificial Intelligence (AI) in Pharmaceutical Basic Information
9.10.2 NVIDIA Corporation Artificial Intelligence (AI) in Pharmaceutical Product Overview
9.10.3 NVIDIA Corporation Artificial Intelligence (AI) in Pharmaceutical Product Market Performance
9.10.4 NVIDIA Corporation Business Overview
9.10.5 NVIDIA Corporation Recent Developments
9.11 Pfizer Inc.
9.11.1 Pfizer Inc. Artificial Intelligence (AI) in Pharmaceutical Basic Information
9.11.2 Pfizer Inc. Artificial Intelligence (AI) in Pharmaceutical Product Overview
9.11.3 Pfizer Inc. Artificial Intelligence (AI) in Pharmaceutical Product Market Performance
9.11.4 Pfizer Inc. Business Overview
9.11.5 Pfizer Inc. Recent Developments
9.12 Recursion Pharmaceuticals Inc.
9.12.1 Recursion Pharmaceuticals Inc. Artificial Intelligence (AI) in Pharmaceutical Basic Information
9.12.2 Recursion Pharmaceuticals Inc. Artificial Intelligence (AI) in Pharmaceutical Product Overview
9.12.3 Recursion Pharmaceuticals Inc. Artificial Intelligence (AI) in Pharmaceutical Product Market Performance
9.12.4 Recursion Pharmaceuticals Inc. Business Overview
9.12.5 Recursion Pharmaceuticals Inc. Recent Developments
9.13 XtalPi Inc
9.13.1 XtalPi Inc Artificial Intelligence (AI) in Pharmaceutical Basic Information
9.13.2 XtalPi Inc Artificial Intelligence (AI) in Pharmaceutical Product Overview
9.13.3 XtalPi Inc Artificial Intelligence (AI) in Pharmaceutical Product Market Performance
9.13.4 XtalPi Inc Business Overview
9.13.5 XtalPi Inc Recent Developments
10 ARTIFICIAL INTELLIGENCE (AI) IN PHARMACEUTICAL MARKET FORECAST BY REGION
10.1 Global Artificial Intelligence (AI) in Pharmaceutical Market Size Forecast
10.2 Global Artificial Intelligence (AI) in Pharmaceutical Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Artificial Intelligence (AI) in Pharmaceutical Market Size Forecast by Country
10.2.3 Asia Pacific Artificial Intelligence (AI) in Pharmaceutical Market Size Forecast by Region
10.2.4 South America Artificial Intelligence (AI) in Pharmaceutical Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Artificial Intelligence (AI) in Pharmaceutical by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Artificial Intelligence (AI) in Pharmaceutical Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Artificial Intelligence (AI) in Pharmaceutical by Type (2025-2030)
11.1.2 Global Artificial Intelligence (AI) in Pharmaceutical Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Artificial Intelligence (AI) in Pharmaceutical by Type (2025-2030)
11.2 Global Artificial Intelligence (AI) in Pharmaceutical Market Forecast by Application (2025-2030)
11.2.1 Global Artificial Intelligence (AI) in Pharmaceutical Sales (K Units) Forecast by Application
11.2.2 Global Artificial Intelligence (AI) in Pharmaceutical Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Artificial Intelligence (AI) in Pharmaceutical Market Size Comparison by Region (M USD)
Table 5. Global Artificial Intelligence (AI) in Pharmaceutical Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Artificial Intelligence (AI) in Pharmaceutical Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Artificial Intelligence (AI) in Pharmaceutical Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Artificial Intelligence (AI) in Pharmaceutical Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Intelligence (AI) in Pharmaceutical as of 2022)
Table 10. Global Market Artificial Intelligence (AI) in Pharmaceutical Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Artificial Intelligence (AI) in Pharmaceutical Sales Sites and Area Served
Table 12. Manufacturers Artificial Intelligence (AI) in Pharmaceutical Product Type
Table 13. Global Artificial Intelligence (AI) in Pharmaceutical Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Artificial Intelligence (AI) in Pharmaceutical
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Artificial Intelligence (AI) in Pharmaceutical Market Challenges
Table 22. Global Artificial Intelligence (AI) in Pharmaceutical Sales by Type (K Units)
Table 23. Global Artificial Intelligence (AI) in Pharmaceutical Market Size by Type (M USD)
Table 24. Global Artificial Intelligence (AI) in Pharmaceutical Sales (K Units) by Type (2019-2024)
Table 25. Global Artificial Intelligence (AI) in Pharmaceutical Sales Market Share by Type (2019-2024)
Table 26. Global Artificial Intelligence (AI) in Pharmaceutical Market Size (M USD) by Type (2019-2024)
Table 27. Global Artificial Intelligence (AI) in Pharmaceutical Market Size Share by Type (2019-2024)
Table 28. Global Artificial Intelligence (AI) in Pharmaceutical Price (USD/Unit) by Type (2019-2024)
Table 29. Global Artificial Intelligence (AI) in Pharmaceutical Sales (K Units) by Application
Table 30. Global Artificial Intelligence (AI) in Pharmaceutical Market Size by Application
Table 31. Global Artificial Intelligence (AI) in Pharmaceutical Sales by Application (2019-2024) & (K Units)
Table 32. Global Artificial Intelligence (AI) in Pharmaceutical Sales Market Share by Application (2019-2024)
Table 33. Global Artificial Intelligence (AI) in Pharmaceutical Sales by Application (2019-2024) & (M USD)
Table 34. Global Artificial Intelligence (AI) in Pharmaceutical Market Share by Application (2019-2024)
Table 35. Global Artificial Intelligence (AI) in Pharmaceutical Sales Growth Rate by Application (2019-2024)
Table 36. Global Artificial Intelligence (AI) in Pharmaceutical Sales by Region (2019-2024) & (K Units)
Table 37. Global Artificial Intelligence (AI) in Pharmaceutical Sales Market Share by Region (2019-2024)
Table 38. North America Artificial Intelligence (AI) in Pharmaceutical Sales by Country (2019-2024) & (K Units)
Table 39. Europe Artificial Intelligence (AI) in Pharmaceutical Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Artificial Intelligence (AI) in Pharmaceutical Sales by Region (2019-2024) & (K Units)
Table 41. South America Artificial Intelligence (AI) in Pharmaceutical Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Artificial Intelligence (AI) in Pharmaceutical Sales by Region (2019-2024) & (K Units)
Table 43. AstraZeneca LLC Artificial Intelligence (AI) in Pharmaceutical Basic Information
Table 44. AstraZeneca LLC Artificial Intelligence (AI) in Pharmaceutical Product Overview
Table 45. AstraZeneca LLC Artificial Intelligence (AI) in Pharmaceutical Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. AstraZeneca LLC Business Overview
Table 47. AstraZeneca LLC Artificial Intelligence (AI) in Pharmaceutical SWOT Analysis
Table 48. AstraZeneca LLC Recent Developments
Table 49. Atomwise Inc Artificial Intelligence (AI) in Pharmaceutical Basic Information
Table 50. Atomwise Inc Artificial Intelligence (AI) in Pharmaceutical Product Overview
Table 51. Atomwise Inc Artificial Intelligence (AI) in Pharmaceutical Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Atomwise Inc Business Overview
Table 53. Atomwise Inc Artificial Intelligence (AI) in Pharmaceutical SWOT Analysis
Table 54. Atomwise Inc Recent Developments
Table 55. Bayer AG Artificial Intelligence (AI) in Pharmaceutical Basic Information
Table 56. Bayer AG Artificial Intelligence (AI) in Pharmaceutical Product Overview
Table 57. Bayer AG Artificial Intelligence (AI) in Pharmaceutical Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Bayer AG Artificial Intelligence (AI) in Pharmaceutical SWOT Analysis
Table 59. Bayer AG Business Overview
Table 60. Bayer AG Recent Developments
Table 61. Cloud Pharmaceuticals Inc Artificial Intelligence (AI) in Pharmaceutical Basic Information
Table 62. Cloud Pharmaceuticals Inc Artificial Intelligence (AI) in Pharmaceutical Product Overview
Table 63. Cloud Pharmaceuticals Inc Artificial Intelligence (AI) in Pharmaceutical Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Cloud Pharmaceuticals Inc Business Overview
Table 65. Cloud Pharmaceuticals Inc Recent Developments
Table 66. GNS Healthcare Artificial Intelligence (AI) in Pharmaceutical Basic Information
Table 67. GNS Healthcare Artificial Intelligence (AI) in Pharmaceutical Product Overview
Table 68. GNS Healthcare Artificial Intelligence (AI) in Pharmaceutical Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. GNS Healthcare Business Overview
Table 70. GNS Healthcare Recent Developments
Table 71. IBM Watson Artificial Intelligence (AI) in Pharmaceutical Basic Information
Table 72. IBM Watson Artificial Intelligence (AI) in Pharmaceutical Product Overview
Table 73. IBM Watson Artificial Intelligence (AI) in Pharmaceutical Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. IBM Watson Business Overview
Table 75. IBM Watson Recent Developments
Table 76. Merck and Co. Artificial Intelligence (AI) in Pharmaceutical Basic Information
Table 77. Merck and Co. Artificial Intelligence (AI) in Pharmaceutical Product Overview
Table 78. Merck and Co. Artificial Intelligence (AI) in Pharmaceutical Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Merck and Co. Business Overview
Table 80. Merck and Co. Recent Developments
Table 81. Microsoft Corporation Artificial Intelligence (AI) in Pharmaceutical Basic Information
Table 82. Microsoft Corporation Artificial Intelligence (AI) in Pharmaceutical Product Overview
Table 83. Microsoft Corporation Artificial Intelligence (AI) in Pharmaceutical Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Microsoft Corporation Business Overview
Table 85. Microsoft Corporation Recent Developments
Table 86. Novartis AG Artificial Intelligence (AI) in Pharmaceutical Basic Information
Table 87. Novartis AG Artificial Intelligence (AI) in Pharmaceutical Product Overview
Table 88. Novartis AG Artificial Intelligence (AI) in Pharmaceutical Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Novartis AG Business Overview
Table 90. Novartis AG Recent Developments
Table 91. NVIDIA Corporation Artificial Intelligence (AI) in Pharmaceutical Basic Information
Table 92. NVIDIA Corporation Artificial Intelligence (AI) in Pharmaceutical Product Overview
Table 93. NVIDIA Corporation Artificial Intelligence (AI) in Pharmaceutical Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. NVIDIA Corporation Business Overview
Table 95. NVIDIA Corporation Recent Developments
Table 96. Pfizer Inc. Artificial Intelligence (AI) in Pharmaceutical Basic Information
Table 97. Pfizer Inc. Artificial Intelligence (AI) in Pharmaceutical Product Overview
Table 98. Pfizer Inc. Artificial Intelligence (AI) in Pharmaceutical Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Pfizer Inc. Business Overview
Table 100. Pfizer Inc. Recent Developments
Table 101. Recursion Pharmaceuticals Inc. Artificial Intelligence (AI) in Pharmaceutical Basic Information
Table 102. Recursion Pharmaceuticals Inc. Artificial Intelligence (AI) in Pharmaceutical Product Overview
Table 103. Recursion Pharmaceuticals Inc. Artificial Intelligence (AI) in Pharmaceutical Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Recursion Pharmaceuticals Inc. Business Overview
Table 105. Recursion Pharmaceuticals Inc. Recent Developments
Table 106. XtalPi Inc Artificial Intelligence (AI) in Pharmaceutical Basic Information
Table 107. XtalPi Inc Artificial Intelligence (AI) in Pharmaceutical Product Overview
Table 108. XtalPi Inc Artificial Intelligence (AI) in Pharmaceutical Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. XtalPi Inc Business Overview
Table 110. XtalPi Inc Recent Developments
Table 111. Global Artificial Intelligence (AI) in Pharmaceutical Sales Forecast by Region (2025-2030) & (K Units)
Table 112. Global Artificial Intelligence (AI) in Pharmaceutical Market Size Forecast by Region (2025-2030) & (M USD)
Table 113. North America Artificial Intelligence (AI) in Pharmaceutical Sales Forecast by Country (2025-2030) & (K Units)
Table 114. North America Artificial Intelligence (AI) in Pharmaceutical Market Size Forecast by Country (2025-2030) & (M USD)
Table 115. Europe Artificial Intelligence (AI) in Pharmaceutical Sales Forecast by Country (2025-2030) & (K Units)
Table 116. Europe Artificial Intelligence (AI) in Pharmaceutical Market Size Forecast by Country (2025-2030) & (M USD)
Table 117. Asia Pacific Artificial Intelligence (AI) in Pharmaceutical Sales Forecast by Region (2025-2030) & (K Units)
Table 118. Asia Pacific Artificial Intelligence (AI) in Pharmaceutical Market Size Forecast by Region (2025-2030) & (M USD)
Table 119. South America Artificial Intelligence (AI) in Pharmaceutical Sales Forecast by Country (2025-2030) & (K Units)
Table 120. South America Artificial Intelligence (AI) in Pharmaceutical Market Size Forecast by Country (2025-2030) & (M USD)
Table 121. Middle East and Africa Artificial Intelligence (AI) in Pharmaceutical Consumption Forecast by Country (2025-2030) & (Units)
Table 122. Middle East and Africa Artificial Intelligence (AI) in Pharmaceutical Market Size Forecast by Country (2025-2030) & (M USD)
Table 123. Global Artificial Intelligence (AI) in Pharmaceutical Sales Forecast by Type (2025-2030) & (K Units)
Table 124. Global Artificial Intelligence (AI) in Pharmaceutical Market Size Forecast by Type (2025-2030) & (M USD)
Table 125. Global Artificial Intelligence (AI) in Pharmaceutical Price Forecast by Type (2025-2030) & (USD/Unit)
Table 126. Global Artificial Intelligence (AI) in Pharmaceutical Sales (K Units) Forecast by Application (2025-2030)
Table 127. Global Artificial Intelligence (AI) in Pharmaceutical Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Artificial Intelligence (AI) in Pharmaceutical Market Size Comparison by Region (M USD)
Table 5. Global Artificial Intelligence (AI) in Pharmaceutical Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Artificial Intelligence (AI) in Pharmaceutical Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Artificial Intelligence (AI) in Pharmaceutical Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Artificial Intelligence (AI) in Pharmaceutical Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Intelligence (AI) in Pharmaceutical as of 2022)
Table 10. Global Market Artificial Intelligence (AI) in Pharmaceutical Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Artificial Intelligence (AI) in Pharmaceutical Sales Sites and Area Served
Table 12. Manufacturers Artificial Intelligence (AI) in Pharmaceutical Product Type
Table 13. Global Artificial Intelligence (AI) in Pharmaceutical Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Artificial Intelligence (AI) in Pharmaceutical
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Artificial Intelligence (AI) in Pharmaceutical Market Challenges
Table 22. Global Artificial Intelligence (AI) in Pharmaceutical Sales by Type (K Units)
Table 23. Global Artificial Intelligence (AI) in Pharmaceutical Market Size by Type (M USD)
Table 24. Global Artificial Intelligence (AI) in Pharmaceutical Sales (K Units) by Type (2019-2024)
Table 25. Global Artificial Intelligence (AI) in Pharmaceutical Sales Market Share by Type (2019-2024)
Table 26. Global Artificial Intelligence (AI) in Pharmaceutical Market Size (M USD) by Type (2019-2024)
Table 27. Global Artificial Intelligence (AI) in Pharmaceutical Market Size Share by Type (2019-2024)
Table 28. Global Artificial Intelligence (AI) in Pharmaceutical Price (USD/Unit) by Type (2019-2024)
Table 29. Global Artificial Intelligence (AI) in Pharmaceutical Sales (K Units) by Application
Table 30. Global Artificial Intelligence (AI) in Pharmaceutical Market Size by Application
Table 31. Global Artificial Intelligence (AI) in Pharmaceutical Sales by Application (2019-2024) & (K Units)
Table 32. Global Artificial Intelligence (AI) in Pharmaceutical Sales Market Share by Application (2019-2024)
Table 33. Global Artificial Intelligence (AI) in Pharmaceutical Sales by Application (2019-2024) & (M USD)
Table 34. Global Artificial Intelligence (AI) in Pharmaceutical Market Share by Application (2019-2024)
Table 35. Global Artificial Intelligence (AI) in Pharmaceutical Sales Growth Rate by Application (2019-2024)
Table 36. Global Artificial Intelligence (AI) in Pharmaceutical Sales by Region (2019-2024) & (K Units)
Table 37. Global Artificial Intelligence (AI) in Pharmaceutical Sales Market Share by Region (2019-2024)
Table 38. North America Artificial Intelligence (AI) in Pharmaceutical Sales by Country (2019-2024) & (K Units)
Table 39. Europe Artificial Intelligence (AI) in Pharmaceutical Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Artificial Intelligence (AI) in Pharmaceutical Sales by Region (2019-2024) & (K Units)
Table 41. South America Artificial Intelligence (AI) in Pharmaceutical Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Artificial Intelligence (AI) in Pharmaceutical Sales by Region (2019-2024) & (K Units)
Table 43. AstraZeneca LLC Artificial Intelligence (AI) in Pharmaceutical Basic Information
Table 44. AstraZeneca LLC Artificial Intelligence (AI) in Pharmaceutical Product Overview
Table 45. AstraZeneca LLC Artificial Intelligence (AI) in Pharmaceutical Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. AstraZeneca LLC Business Overview
Table 47. AstraZeneca LLC Artificial Intelligence (AI) in Pharmaceutical SWOT Analysis
Table 48. AstraZeneca LLC Recent Developments
Table 49. Atomwise Inc Artificial Intelligence (AI) in Pharmaceutical Basic Information
Table 50. Atomwise Inc Artificial Intelligence (AI) in Pharmaceutical Product Overview
Table 51. Atomwise Inc Artificial Intelligence (AI) in Pharmaceutical Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Atomwise Inc Business Overview
Table 53. Atomwise Inc Artificial Intelligence (AI) in Pharmaceutical SWOT Analysis
Table 54. Atomwise Inc Recent Developments
Table 55. Bayer AG Artificial Intelligence (AI) in Pharmaceutical Basic Information
Table 56. Bayer AG Artificial Intelligence (AI) in Pharmaceutical Product Overview
Table 57. Bayer AG Artificial Intelligence (AI) in Pharmaceutical Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Bayer AG Artificial Intelligence (AI) in Pharmaceutical SWOT Analysis
Table 59. Bayer AG Business Overview
Table 60. Bayer AG Recent Developments
Table 61. Cloud Pharmaceuticals Inc Artificial Intelligence (AI) in Pharmaceutical Basic Information
Table 62. Cloud Pharmaceuticals Inc Artificial Intelligence (AI) in Pharmaceutical Product Overview
Table 63. Cloud Pharmaceuticals Inc Artificial Intelligence (AI) in Pharmaceutical Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Cloud Pharmaceuticals Inc Business Overview
Table 65. Cloud Pharmaceuticals Inc Recent Developments
Table 66. GNS Healthcare Artificial Intelligence (AI) in Pharmaceutical Basic Information
Table 67. GNS Healthcare Artificial Intelligence (AI) in Pharmaceutical Product Overview
Table 68. GNS Healthcare Artificial Intelligence (AI) in Pharmaceutical Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. GNS Healthcare Business Overview
Table 70. GNS Healthcare Recent Developments
Table 71. IBM Watson Artificial Intelligence (AI) in Pharmaceutical Basic Information
Table 72. IBM Watson Artificial Intelligence (AI) in Pharmaceutical Product Overview
Table 73. IBM Watson Artificial Intelligence (AI) in Pharmaceutical Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. IBM Watson Business Overview
Table 75. IBM Watson Recent Developments
Table 76. Merck and Co. Artificial Intelligence (AI) in Pharmaceutical Basic Information
Table 77. Merck and Co. Artificial Intelligence (AI) in Pharmaceutical Product Overview
Table 78. Merck and Co. Artificial Intelligence (AI) in Pharmaceutical Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Merck and Co. Business Overview
Table 80. Merck and Co. Recent Developments
Table 81. Microsoft Corporation Artificial Intelligence (AI) in Pharmaceutical Basic Information
Table 82. Microsoft Corporation Artificial Intelligence (AI) in Pharmaceutical Product Overview
Table 83. Microsoft Corporation Artificial Intelligence (AI) in Pharmaceutical Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Microsoft Corporation Business Overview
Table 85. Microsoft Corporation Recent Developments
Table 86. Novartis AG Artificial Intelligence (AI) in Pharmaceutical Basic Information
Table 87. Novartis AG Artificial Intelligence (AI) in Pharmaceutical Product Overview
Table 88. Novartis AG Artificial Intelligence (AI) in Pharmaceutical Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Novartis AG Business Overview
Table 90. Novartis AG Recent Developments
Table 91. NVIDIA Corporation Artificial Intelligence (AI) in Pharmaceutical Basic Information
Table 92. NVIDIA Corporation Artificial Intelligence (AI) in Pharmaceutical Product Overview
Table 93. NVIDIA Corporation Artificial Intelligence (AI) in Pharmaceutical Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. NVIDIA Corporation Business Overview
Table 95. NVIDIA Corporation Recent Developments
Table 96. Pfizer Inc. Artificial Intelligence (AI) in Pharmaceutical Basic Information
Table 97. Pfizer Inc. Artificial Intelligence (AI) in Pharmaceutical Product Overview
Table 98. Pfizer Inc. Artificial Intelligence (AI) in Pharmaceutical Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Pfizer Inc. Business Overview
Table 100. Pfizer Inc. Recent Developments
Table 101. Recursion Pharmaceuticals Inc. Artificial Intelligence (AI) in Pharmaceutical Basic Information
Table 102. Recursion Pharmaceuticals Inc. Artificial Intelligence (AI) in Pharmaceutical Product Overview
Table 103. Recursion Pharmaceuticals Inc. Artificial Intelligence (AI) in Pharmaceutical Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Recursion Pharmaceuticals Inc. Business Overview
Table 105. Recursion Pharmaceuticals Inc. Recent Developments
Table 106. XtalPi Inc Artificial Intelligence (AI) in Pharmaceutical Basic Information
Table 107. XtalPi Inc Artificial Intelligence (AI) in Pharmaceutical Product Overview
Table 108. XtalPi Inc Artificial Intelligence (AI) in Pharmaceutical Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. XtalPi Inc Business Overview
Table 110. XtalPi Inc Recent Developments
Table 111. Global Artificial Intelligence (AI) in Pharmaceutical Sales Forecast by Region (2025-2030) & (K Units)
Table 112. Global Artificial Intelligence (AI) in Pharmaceutical Market Size Forecast by Region (2025-2030) & (M USD)
Table 113. North America Artificial Intelligence (AI) in Pharmaceutical Sales Forecast by Country (2025-2030) & (K Units)
Table 114. North America Artificial Intelligence (AI) in Pharmaceutical Market Size Forecast by Country (2025-2030) & (M USD)
Table 115. Europe Artificial Intelligence (AI) in Pharmaceutical Sales Forecast by Country (2025-2030) & (K Units)
Table 116. Europe Artificial Intelligence (AI) in Pharmaceutical Market Size Forecast by Country (2025-2030) & (M USD)
Table 117. Asia Pacific Artificial Intelligence (AI) in Pharmaceutical Sales Forecast by Region (2025-2030) & (K Units)
Table 118. Asia Pacific Artificial Intelligence (AI) in Pharmaceutical Market Size Forecast by Region (2025-2030) & (M USD)
Table 119. South America Artificial Intelligence (AI) in Pharmaceutical Sales Forecast by Country (2025-2030) & (K Units)
Table 120. South America Artificial Intelligence (AI) in Pharmaceutical Market Size Forecast by Country (2025-2030) & (M USD)
Table 121. Middle East and Africa Artificial Intelligence (AI) in Pharmaceutical Consumption Forecast by Country (2025-2030) & (Units)
Table 122. Middle East and Africa Artificial Intelligence (AI) in Pharmaceutical Market Size Forecast by Country (2025-2030) & (M USD)
Table 123. Global Artificial Intelligence (AI) in Pharmaceutical Sales Forecast by Type (2025-2030) & (K Units)
Table 124. Global Artificial Intelligence (AI) in Pharmaceutical Market Size Forecast by Type (2025-2030) & (M USD)
Table 125. Global Artificial Intelligence (AI) in Pharmaceutical Price Forecast by Type (2025-2030) & (USD/Unit)
Table 126. Global Artificial Intelligence (AI) in Pharmaceutical Sales (K Units) Forecast by Application (2025-2030)
Table 127. Global Artificial Intelligence (AI) in Pharmaceutical Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Artificial Intelligence (AI) in Pharmaceutical
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Artificial Intelligence (AI) in Pharmaceutical Market Size (M USD), 2019-2030
Figure 5. Global Artificial Intelligence (AI) in Pharmaceutical Market Size (M USD) (2019-2030)
Figure 6. Global Artificial Intelligence (AI) in Pharmaceutical Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Artificial Intelligence (AI) in Pharmaceutical Market Size by Country (M USD)
Figure 11. Artificial Intelligence (AI) in Pharmaceutical Sales Share by Manufacturers in 2023
Figure 12. Global Artificial Intelligence (AI) in Pharmaceutical Revenue Share by Manufacturers in 2023
Figure 13. Artificial Intelligence (AI) in Pharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Artificial Intelligence (AI) in Pharmaceutical Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Artificial Intelligence (AI) in Pharmaceutical Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Artificial Intelligence (AI) in Pharmaceutical Market Share by Type
Figure 18. Sales Market Share of Artificial Intelligence (AI) in Pharmaceutical by Type (2019-2024)
Figure 19. Sales Market Share of Artificial Intelligence (AI) in Pharmaceutical by Type in 2023
Figure 20. Market Size Share of Artificial Intelligence (AI) in Pharmaceutical by Type (2019-2024)
Figure 21. Market Size Market Share of Artificial Intelligence (AI) in Pharmaceutical by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Artificial Intelligence (AI) in Pharmaceutical Market Share by Application
Figure 24. Global Artificial Intelligence (AI) in Pharmaceutical Sales Market Share by Application (2019-2024)
Figure 25. Global Artificial Intelligence (AI) in Pharmaceutical Sales Market Share by Application in 2023
Figure 26. Global Artificial Intelligence (AI) in Pharmaceutical Market Share by Application (2019-2024)
Figure 27. Global Artificial Intelligence (AI) in Pharmaceutical Market Share by Application in 2023
Figure 28. Global Artificial Intelligence (AI) in Pharmaceutical Sales Growth Rate by Application (2019-2024)
Figure 29. Global Artificial Intelligence (AI) in Pharmaceutical Sales Market Share by Region (2019-2024)
Figure 30. North America Artificial Intelligence (AI) in Pharmaceutical Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Artificial Intelligence (AI) in Pharmaceutical Sales Market Share by Country in 2023
Figure 32. U.S. Artificial Intelligence (AI) in Pharmaceutical Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Artificial Intelligence (AI) in Pharmaceutical Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Artificial Intelligence (AI) in Pharmaceutical Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Artificial Intelligence (AI) in Pharmaceutical Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Artificial Intelligence (AI) in Pharmaceutical Sales Market Share by Country in 2023
Figure 37. Germany Artificial Intelligence (AI) in Pharmaceutical Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Artificial Intelligence (AI) in Pharmaceutical Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Artificial Intelligence (AI) in Pharmaceutical Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Artificial Intelligence (AI) in Pharmaceutical Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Artificial Intelligence (AI) in Pharmaceutical Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Artificial Intelligence (AI) in Pharmaceutical Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Artificial Intelligence (AI) in Pharmaceutical Sales Market Share by Region in 2023
Figure 44. China Artificial Intelligence (AI) in Pharmaceutical Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Artificial Intelligence (AI) in Pharmaceutical Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Artificial Intelligence (AI) in Pharmaceutical Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Artificial Intelligence (AI) in Pharmaceutical Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Artificial Intelligence (AI) in Pharmaceutical Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Artificial Intelligence (AI) in Pharmaceutical Sales and Growth Rate (K Units)
Figure 50. South America Artificial Intelligence (AI) in Pharmaceutical Sales Market Share by Country in 2023
Figure 51. Brazil Artificial Intelligence (AI) in Pharmaceutical Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Artificial Intelligence (AI) in Pharmaceutical Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Artificial Intelligence (AI) in Pharmaceutical Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Artificial Intelligence (AI) in Pharmaceutical Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Artificial Intelligence (AI) in Pharmaceutical Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Artificial Intelligence (AI) in Pharmaceutical Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Artificial Intelligence (AI) in Pharmaceutical Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Artificial Intelligence (AI) in Pharmaceutical Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Artificial Intelligence (AI) in Pharmaceutical Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Artificial Intelligence (AI) in Pharmaceutical Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Artificial Intelligence (AI) in Pharmaceutical Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Artificial Intelligence (AI) in Pharmaceutical Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Artificial Intelligence (AI) in Pharmaceutical Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Artificial Intelligence (AI) in Pharmaceutical Market Share Forecast by Type (2025-2030)
Figure 65. Global Artificial Intelligence (AI) in Pharmaceutical Sales Forecast by Application (2025-2030)
Figure 66. Global Artificial Intelligence (AI) in Pharmaceutical Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Artificial Intelligence (AI) in Pharmaceutical
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Artificial Intelligence (AI) in Pharmaceutical Market Size (M USD), 2019-2030
Figure 5. Global Artificial Intelligence (AI) in Pharmaceutical Market Size (M USD) (2019-2030)
Figure 6. Global Artificial Intelligence (AI) in Pharmaceutical Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Artificial Intelligence (AI) in Pharmaceutical Market Size by Country (M USD)
Figure 11. Artificial Intelligence (AI) in Pharmaceutical Sales Share by Manufacturers in 2023
Figure 12. Global Artificial Intelligence (AI) in Pharmaceutical Revenue Share by Manufacturers in 2023
Figure 13. Artificial Intelligence (AI) in Pharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Artificial Intelligence (AI) in Pharmaceutical Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Artificial Intelligence (AI) in Pharmaceutical Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Artificial Intelligence (AI) in Pharmaceutical Market Share by Type
Figure 18. Sales Market Share of Artificial Intelligence (AI) in Pharmaceutical by Type (2019-2024)
Figure 19. Sales Market Share of Artificial Intelligence (AI) in Pharmaceutical by Type in 2023
Figure 20. Market Size Share of Artificial Intelligence (AI) in Pharmaceutical by Type (2019-2024)
Figure 21. Market Size Market Share of Artificial Intelligence (AI) in Pharmaceutical by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Artificial Intelligence (AI) in Pharmaceutical Market Share by Application
Figure 24. Global Artificial Intelligence (AI) in Pharmaceutical Sales Market Share by Application (2019-2024)
Figure 25. Global Artificial Intelligence (AI) in Pharmaceutical Sales Market Share by Application in 2023
Figure 26. Global Artificial Intelligence (AI) in Pharmaceutical Market Share by Application (2019-2024)
Figure 27. Global Artificial Intelligence (AI) in Pharmaceutical Market Share by Application in 2023
Figure 28. Global Artificial Intelligence (AI) in Pharmaceutical Sales Growth Rate by Application (2019-2024)
Figure 29. Global Artificial Intelligence (AI) in Pharmaceutical Sales Market Share by Region (2019-2024)
Figure 30. North America Artificial Intelligence (AI) in Pharmaceutical Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Artificial Intelligence (AI) in Pharmaceutical Sales Market Share by Country in 2023
Figure 32. U.S. Artificial Intelligence (AI) in Pharmaceutical Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Artificial Intelligence (AI) in Pharmaceutical Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Artificial Intelligence (AI) in Pharmaceutical Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Artificial Intelligence (AI) in Pharmaceutical Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Artificial Intelligence (AI) in Pharmaceutical Sales Market Share by Country in 2023
Figure 37. Germany Artificial Intelligence (AI) in Pharmaceutical Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Artificial Intelligence (AI) in Pharmaceutical Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Artificial Intelligence (AI) in Pharmaceutical Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Artificial Intelligence (AI) in Pharmaceutical Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Artificial Intelligence (AI) in Pharmaceutical Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Artificial Intelligence (AI) in Pharmaceutical Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Artificial Intelligence (AI) in Pharmaceutical Sales Market Share by Region in 2023
Figure 44. China Artificial Intelligence (AI) in Pharmaceutical Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Artificial Intelligence (AI) in Pharmaceutical Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Artificial Intelligence (AI) in Pharmaceutical Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Artificial Intelligence (AI) in Pharmaceutical Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Artificial Intelligence (AI) in Pharmaceutical Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Artificial Intelligence (AI) in Pharmaceutical Sales and Growth Rate (K Units)
Figure 50. South America Artificial Intelligence (AI) in Pharmaceutical Sales Market Share by Country in 2023
Figure 51. Brazil Artificial Intelligence (AI) in Pharmaceutical Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Artificial Intelligence (AI) in Pharmaceutical Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Artificial Intelligence (AI) in Pharmaceutical Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Artificial Intelligence (AI) in Pharmaceutical Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Artificial Intelligence (AI) in Pharmaceutical Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Artificial Intelligence (AI) in Pharmaceutical Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Artificial Intelligence (AI) in Pharmaceutical Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Artificial Intelligence (AI) in Pharmaceutical Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Artificial Intelligence (AI) in Pharmaceutical Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Artificial Intelligence (AI) in Pharmaceutical Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Artificial Intelligence (AI) in Pharmaceutical Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Artificial Intelligence (AI) in Pharmaceutical Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Artificial Intelligence (AI) in Pharmaceutical Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Artificial Intelligence (AI) in Pharmaceutical Market Share Forecast by Type (2025-2030)
Figure 65. Global Artificial Intelligence (AI) in Pharmaceutical Sales Forecast by Application (2025-2030)
Figure 66. Global Artificial Intelligence (AI) in Pharmaceutical Market Share Forecast by Application (2025-2030)
